Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy
Prostate Cancer & Prostatic Diseases, 10/21/2010Abdollah F et al.
The objective was to test the hypothesis that in patients with prostate cancer undergoing radical prostatectomy (RP), diabetic patients are at a higher risk of harboring a high–grade tumor than non–diabetic patients. Authors examined 2060 consecutive men who underwent RP between 2001 and 2009. Of them, 7.1% had type 2 diabetes mellitus (DM). A high–grade tumor was defined as having a Gleason score >=8. In multivariable analyses, DM was an independent predictor of high–grade tumor on biopsy and on final pathological specimen. In patients undergoing RP, those with type 2 DM had a higher risk of harboring a poorly differentiated tumor on final pathological examination.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.